BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21470977)

  • 1. Helper-dependent adenoviral vectors for liver-directed gene therapy.
    Brunetti-Pierri N; Ng P
    Hum Mol Genet; 2011 Apr; 20(R1):R7-13. PubMed ID: 21470977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.
    Piccolo P; Brunetti-Pierri N
    Biomedicines; 2014 Apr; 2(2):132-148. PubMed ID: 28548064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges.
    Vetrini F; Ng P
    Curr Pharm Des; 2011; 17(24):2488-99. PubMed ID: 21774769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.
    Brunetti-Pierri N; Ng P
    Virus Genes; 2017 Oct; 53(5):684-691. PubMed ID: 28593513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.
    Seiler MP; Cerullo V; Lee B
    Curr Gene Ther; 2007 Oct; 7(5):297-305. PubMed ID: 17979676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors.
    Brunetti-Pierri N; Clarke C; Mane V; Palmer DJ; Lanpher B; Sun Q; O'Brien W; Lee B
    J Gene Med; 2008 Aug; 10(8):890-6. PubMed ID: 18563850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in helper-dependent adenoviral vector--a review review].
    Fu Y; He J; Shi C; Hong T
    Wei Sheng Wu Xue Bao; 2009 Feb; 49(2):147-52. PubMed ID: 19445167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal injection of helper-dependent adenoviral vectors results in long-term transgene expression in neuroependymal cells and neurons.
    Dindot S; Piccolo P; Grove N; Palmer D; Brunetti-Pierri N
    Hum Gene Ther; 2011 Jun; 22(6):745-51. PubMed ID: 21175294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper-dependent adenoviral vectors in experimental gene therapy.
    Józkowicz A; Dulak J
    Acta Biochim Pol; 2005; 52(3):589-99. PubMed ID: 16082408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.
    Oka K; Belalcazar LM; Dieker C; Nour EA; Nuno-Gonzalez P; Paul A; Cormier S; Shin JK; Finegold M; Chan L
    Gene Ther; 2007 Feb; 14(3):191-202. PubMed ID: 16957769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors.
    Brunetti-Pierri N; Ng T; Iannitti D; Cioffi W; Stapleton G; Law M; Breinholt J; Palmer D; Grove N; Rice K; Bauer C; Finegold M; Beaudet A; Mullins C; Ng P
    Hum Gene Ther; 2013 Aug; 24(8):761-5. PubMed ID: 23902403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper-dependent adenoviral vectors for gene therapy.
    Palmer DJ; Ng P
    Hum Gene Ther; 2005 Jan; 16(1):1-16. PubMed ID: 15703484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy.
    Brunetti-Pierri N; Ng P
    Curr Opin Mol Ther; 2006 Oct; 8(5):446-54. PubMed ID: 17078387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress towards liver and lung-directed gene therapy with helper-dependent adenoviral vectors.
    Brunetti-Pierri N; Ng P
    Curr Gene Ther; 2009 Oct; 9(5):329-40. PubMed ID: 19860648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy.
    Brunetti-Pierri N; Stapleton GE; Palmer DJ; Zuo Y; Mane VP; Finegold MJ; Beaudet AL; Leland MM; Mullins CE; Ng P
    Mol Ther; 2007 Apr; 15(4):732-40. PubMed ID: 17285138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors.
    Brunetti-Pierri N; Ng P
    Gene Ther; 2008 Apr; 15(8):553-60. PubMed ID: 18288209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in helper-dependent adenoviral vector research.
    Segura MM; Alba R; Bosch A; Chillón M
    Curr Gene Ther; 2008 Aug; 8(4):222-35. PubMed ID: 18691018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaques.
    Brunetti-Pierri N; Liou A; Patel P; Palmer D; Grove N; Finegold M; Piccolo P; Donnachie E; Rice K; Beaudet A; Mullins C; Ng P
    Mol Ther; 2012 Oct; 20(10):1863-70. PubMed ID: 22828499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR-A and SREC-I binding peptides increase HDAd-mediated liver transduction.
    Piccolo P; Annunziata P; Mithbaokar P; Brunetti-Pierri N
    Gene Ther; 2014 Nov; 21(11):950-7. PubMed ID: 25119377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helper-Dependent Adenoviral Vectors and Their Use for Neuroscience Applications.
    Montesinos MS; Satterfield R; Young SM
    Methods Mol Biol; 2016; 1474():73-90. PubMed ID: 27515075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.